Načítá se...

LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7

Hepatocellular carcinoma (HCC) is recognized for its high mortality rate worldwide. Based on intensive studies, long non-coding RNA (lncRNA) expression exerts significant effects on tumor suppression. Herein, we investigated the molecular mechanism of lymphoid enhancer-binding factor-1 antisense RNA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Cycle
Hlavní autoři: Gao, Jun, Dai, Chao, Yu, Xin, Yin, Xiang-Bao, Zhou, Fan
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7217375/
https://ncbi.nlm.nih.gov/pubmed/32178558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1731052
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!